NewsSouthern Africa’s Cannabis Ambitions

Southern Africa’s Cannabis Ambitions


THE Malawi Parliament has backed a bill allowing for the cultivation of cannabis for industrial and medicinal purposes. 

The country is joining a growing list of southern African nations opening their doors to the cannabis industry

Zimbabwe, Lesotho and South Africa all permit medical cannabis and hemp production with the latter decriminalizing the recreational use of cannabis in 2018.

Malawi says the move towards hemp and cannabis will reduce its reliance on on tobacco, which accounts for about 13% of its gross domestic product and 60% of its foreign exchange earnings.

Lesotho has a history of illegal cannabis production stretching back centuries and became the first African country to approve medical pot cultivation in 2017.

Ontario-based Aphria last year launched joint venture with UK extraction company Verve Dynamics. This JV, known as Cann Invest Africa, aims to export Lesotho CBD to global markets. 

Vic Neufeld, CEO of Aphria which prides itself on being a value for money cannabis proposition, said: “Given the abundant natural resources and our collective expertise and that of our partners, Verve is poised to become one of the lowest-cost producers of medical cannabis extracts in the world.” 

A second Canadian cannabis company has beaten a path to Lesotho, with Toronto-based Supreme Cannabis Company investing $10m into Medigrow, giving it a 10% share of the business.

Medigrow was granted permission by the Lesotho government to begin cultivation in 2016 and the partners have entered into a long-term, distribution partnership which will see cannabis oil exported to Canada and elsewhere.

UK medical cannabis firm Eco Equity has started work on a £5m medical cannabis cultivation business in Zimbabwe.

Based in London, it is one of 40 foreign and domestic companies to have secured a licence to grow in the African country since it changed the law last year.

‘The African Cannabis Report’– published by Prohibition Partners, estimated that Africa’s legal Cannabis market could be worth over US$7.1 billion by 2023.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest

LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE),...

German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found

EARLIER this month news broke that recent analysis conducted by the Bundestag's scientific service suggested the creation of a...

‘Collaborative Vertical Integration Has To Be The Way Forward For the European Cannabis Industry’

BACK in 2019 at a US industry conference while discussing cannabis business models a top executive from JP...

SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility

SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new state-of-the-art pharmaceutical EU-GMP facility in Portugal. SOMAÍ’s phase 1 manufacturing...

Must read

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many...

You might also likeRELATED
Recommended to you